rs113571926
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_014339.7(IL17RA):c.2268C>A(p.Phe756Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,610,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_014339.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL17RA | NM_014339.7 | c.2268C>A | p.Phe756Leu | missense_variant | 13/13 | ENST00000319363.11 | NP_055154.3 | |
IL17RA | NM_001289905.2 | c.2166C>A | p.Phe722Leu | missense_variant | 12/12 | NP_001276834.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL17RA | ENST00000319363.11 | c.2268C>A | p.Phe756Leu | missense_variant | 13/13 | 1 | NM_014339.7 | ENSP00000320936.6 | ||
IL17RA | ENST00000612619.2 | c.2166C>A | p.Phe722Leu | missense_variant | 12/12 | 5 | ENSP00000479970.1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152230Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000125 AC: 3AN: 239922Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 130726
GnomAD4 exome AF: 0.00000960 AC: 14AN: 1457676Hom.: 0 Cov.: 36 AF XY: 0.0000124 AC XY: 9AN XY: 724800
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152348Hom.: 0 Cov.: 34 AF XY: 0.0000268 AC XY: 2AN XY: 74496
ClinVar
Submissions by phenotype
Immunodeficiency 51 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 28, 2021 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 07, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at